These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 18391892)
1. Epidemiology of antiretroviral resistance and impact on treatment outcomes. Cane P J HIV Ther; 2007 Dec; 12(4):82-4. PubMed ID: 18391892 [No Abstract] [Full Text] [Related]
2. Antiretroviral resistance in the developing world. Pillay D J HIV Ther; 2007 Dec; 12(4):95-6. PubMed ID: 18578091 [No Abstract] [Full Text] [Related]
3. Resistance to antiretroviral drugs: a threat to the prevention and treatment of pediatric HIV infection. Krogstad PA J Infect Dis; 2007 May; 195(10):1393-5. PubMed ID: 17436216 [No Abstract] [Full Text] [Related]
5. Slow accumulation of HIV resistance mutations: implications for resource-limited settings? Stevens WS J Infect Dis; 2009 Sep; 200(5):670-2. PubMed ID: 19604045 [No Abstract] [Full Text] [Related]
6. The K65R mutation: selection, frequency, and possible consequences. Moyle GJ AIDS Read; 2004 Nov; 14(11):595-7, 601-3. PubMed ID: 15570671 [No Abstract] [Full Text] [Related]
7. Successful application of laboratory tools for the detection of HIV drug resistance in routine clinical care in Georgia. Chkhartishvili N; Dvali N; Gochitashvili N; Sharvadze L; Tsertsvadze T Georgian Med News; 2008 Dec; (165):16-22. PubMed ID: 19124911 [TBL] [Abstract][Full Text] [Related]
9. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)]. ; Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554 [No Abstract] [Full Text] [Related]
10. [Four years without resistance--newer standard in HIV therapy]. Dtsch Med Wochenschr; 2003 May; 128(19):1075-6. PubMed ID: 12774798 [No Abstract] [Full Text] [Related]
11. Antiretroviral rounds. Resistance: how do you know if you don't know? Campbell TB; Katzenstein D AIDS Clin Care; 2005 Mar; 17(3):26-7. PubMed ID: 15828117 [No Abstract] [Full Text] [Related]
13. Low levels of antiretroviral-resistant HIV infection in a routine clinic in Cameroon that uses the World Health Organization (WHO) public health approach to monitor antiretroviral treatment and adequacy with the WHO recommendation for second-line treatment. Kouanfack C; Montavon C; Laurent C; Aghokeng A; Kenfack A; Bourgeois A; Koulla-Shiro S; Mpoudi-Ngole E; Peeters M; Delaporte E Clin Infect Dis; 2009 May; 48(9):1318-22. PubMed ID: 19320592 [TBL] [Abstract][Full Text] [Related]
14. [German-Austrian guidelines for antiretroviral therapy of HIV infection. (July, 2002, update)]. Brockmeyer NH; ; Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S7-18. PubMed ID: 12736863 [No Abstract] [Full Text] [Related]
15. HIV drug resistance and you. Resistance overview. A look at the basics. Munk B Posit Aware; 2006; Spec No():6-9. PubMed ID: 16583502 [No Abstract] [Full Text] [Related]
18. Guideline watch. Antiretroviral drug resistance testing--updated guidelines from the IAS-USA. Hicks CB AIDS Clin Care; 2008 Aug; 20(8):64. PubMed ID: 18814369 [No Abstract] [Full Text] [Related]
19. Clinical data marshalled to treat HIV. Clarke T Nature; 2003 Jun; 423(6942):791. PubMed ID: 12815390 [No Abstract] [Full Text] [Related]
20. The importance of being earnest. Specific advantages and new treatment options for the un-undetectable. Berger DS Posit Aware; 2007; 18(2):37. PubMed ID: 17390490 [No Abstract] [Full Text] [Related] [Next] [New Search]